levodopa has been researched along with Cerebral Pseudosclerosis in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (72.73) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jankovic, J; Niemann, N | 1 |
| Arcaya, JL; Salazar, U; Silva, EJ; Tejeda, CM; Urdaneta, K; Varela, K | 1 |
| Lalla, R; Patil, TB; Verma, R | 1 |
| Albizzati, MG; Bassi, S; Frattola, L; Spano, PF; Trabucchi, M | 1 |
| Markova, ED; Shmidt, EV; Tkachev, RA | 1 |
| Gerstenbrand, F; Gründig, E; Weiss, J | 1 |
| Klawans, HL; Weiner, WJ | 1 |
| Sears, ES | 1 |
| Davidson, DL; Mawdsley, C; Pullar, IA; Wilson, H; Yates, CM | 1 |
| Mortimer, JA; Webster, DD | 1 |
| Bukhovtsev, PP; Mis'kiv, IaI; Proniv, DI; Sirotina, OS | 1 |
2 review(s) available for levodopa and Cerebral Pseudosclerosis
| Article | Year |
|---|---|
Juvenile parkinsonism: Differential diagnosis, genetics, and treatment.
Topics: Adolescent; alpha-Synuclein; Antiparkinson Agents; Child; Child, Preschool; Deep Brain Stimulation; Diagnosis, Differential; DiGeorge Syndrome; Dystonic Disorders; Genetic Diseases, X-Linked; Hepatolenticular Degeneration; Humans; Huntington Disease; Levodopa; Parkinsonian Disorders; Protein Deglycase DJ-1; Protein Kinases; Spinocerebellar Ataxias; Ubiquitin-Protein Ligases; Young Adult | 2019 |
The pharmacology of choreatic movement disorders.
Topics: Acetylcholine; Acute Disease; Amphetamine; Chorea; Dopamine; gamma-Aminobutyric Acid; Hepatolenticular Degeneration; Humans; Huntington Disease; Hyperthyroidism; Levodopa; Lupus Erythematosus, Systemic; Movement Disorders; Serotonin | 1976 |
9 other study(ies) available for levodopa and Cerebral Pseudosclerosis
| Article | Year |
|---|---|
[Copper intoxication decreases lifespan and induces neurologic alterations in Drosophila melanogaster].
Topics: Age Factors; Animals; Copper Sulfate; Disease Models, Animal; Disease Progression; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopaminergic Neurons; Drosophila melanogaster; Female; Fluphenazine; Hepatolenticular Degeneration; Humans; Levodopa; Longevity; Male; Motor Activity; Sampling Studies; Synaptic Transmission | 2013 |
Is blinking of the eyes affected in extrapyramidal disorders? An interesting observation in a patient with Wilson disease.
Topics: Adult; Antiparkinson Agents; Basal Ganglia Diseases; Blinking; Carbidopa; Ceruloplasmin; Drug Therapy, Combination; Female; Hepatolenticular Degeneration; Humans; Levodopa; Penicillamine; Trihexyphenidyl; Zinc Sulfate | 2012 |
Treatment of dyskinetic and dystonic disorders with CF 25-397: clinical and pharmacological aspects.
Topics: Aged; Carbidopa; Dystonia; Ergolines; Female; Hepatolenticular Degeneration; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1980 |
[Current problems in the diagnosis and treatment of hereditary diseases of the nervous system].
Topics: Basal Ganglia Diseases; Catecholamines; Dystonia Musculorum Deformans; Female; Genetic Carrier Screening; Hepatolenticular Degeneration; Humans; Levodopa; Nervous System Diseases; Polymorphism, Genetic; Pregnancy; Prenatal Diagnosis | 1982 |
[The activity of aminotransferases in serum and cerebrospinal fluid in neurological diseases (author's transl)].
Topics: Alanine Transaminase; Amyotrophic Lateral Sclerosis; Aspartate Aminotransferases; Craniocerebral Trauma; Friedreich Ataxia; Guanidines; Hepatolenticular Degeneration; Humans; Huntington Disease; Levodopa; Nervous System Diseases; Parkinson Disease; Penicillins; Phenylketonurias; Transaminases | 1975 |
Therapeutics of disordered movement.
Topics: Carbidopa; Chorea; Drug Administration Schedule; Dyskinesia, Drug-Induced; Dystonia Musculorum Deformans; Hepatolenticular Degeneration; Humans; Huntington Disease; Levodopa; Movement Disorders; Parasympatholytics; Parkinson Disease; Receptors, Cholinergic; Receptors, Dopamine; Tremor | 1977 |
CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders.
Topics: Aged; Athetosis; Carbidopa; Chorea; Dihydroxyphenylalanine; Dopamine; Dystonia Musculorum Deformans; Hepatolenticular Degeneration; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methoxyhydroxyphenylglycol; Middle Aged; Movement Disorders; Parkinson Disease; Parkinson Disease, Postencephalitic; Serotonin; Tetrabenazine; Torticollis | 1977 |
Failure of L-dopa to relieve activated rigidity in Parkinson's disease.
Topics: Adult; Amantadine; Extrapyramidal Tracts; Hepatolenticular Degeneration; Humans; Levodopa; Male; Middle Aged; Muscle Contraction; Parkinson Disease; Penicillamine; Thalamus | 1977 |
[Use of the preparation L-dopa in parkinsonism].
Topics: Adolescent; Adult; Aged; Drug Evaluation; Drug Therapy, Combination; Female; Hepatolenticular Degeneration; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Postencephalitic | 1976 |